In March 2025, the company announced new ideas for the direct-to-buyer presenting of its Wegovy weight loss drug. The company recognized a new pharmacy, named NovoCare, which would cost prospects $499 monthly for entry to the drug, a lot less than half the cost of the drug via other pharmaceutical distribution networks.[53]The maker says that good